Join
Live feed
·
INSIDERFilingvia Quantisnow
Pacira BioSciences Inc. logo

Director Froimson Mark bought $16,212 worth of shares (1,400 units at $11.58), increasing direct ownership by 11% to 14,473 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PCRX· Pacira BioSciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PCRX (Pacira BioSciences Inc.) and more on Quantisnow.